The WiSE®-UP Registry for Heart Failure
This registry is studying the WiSE CRT System, an implantable device that helps your heart pump blood more effectively. It works by providing electrical stimulation to both the left and right sides of your heart (biventricular pacing). The goal is to understand how well the WiSE System performs in real-world use, including its safety and how it affects patients with heart failure. You may be able to join if you are planned to receive a WiSE System and meet certain screening requirements. The study will track safety over several years, up to 60 months. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will watch and collect information about patients using the WiSE System. It plans to enroll 320 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for safety at 1, 6, 12, 24, 48, and 60 months after receiving the device.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
At a glance
Conditions
NCT07098858
Where you'd take part
This study runs at 12 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Arrhythmia Research Group (St. Bernards Hospital)
Jonesboro, Arkansasstudy coordinator listed
Recruiting
CardioVascular Associates of Mesa (CVAM)
Mesa, Arizonastudy coordinator listed
Not yet recruiting
Cleveland Clinic Foundation
Cleveland, Ohiostudy coordinator listed
Recruiting
Honor Health
Scottsdale, Arizonastudy coordinator listed
Recruiting
MUSC
Charleston, South Carolinastudy coordinator listed
Recruiting
Naples Community Hospital
Naples, Floridastudy coordinator listed
Recruiting
Penn State Health
Hershey, Pennsylvaniastudy coordinator listed
Recruiting
St. Luke's Hospital of Kansas City
Kansas City, Missouristudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Primary Safety1, 6, 12, 24, 48 and 60 months
The primary outcome measure of the Study is the rate of serious adverse events (SAEs) at \< 30 days post implant related to the WiSE System and/or implant procedure.